Informed weight management

Semaglutide: why weight loss is not the same every week

Learn why semaglutide does not produce a fixed weekly rate of weight loss and how to read study averages without turning them into promises.

Produced byLevia editorial team3 min readUpdated on September 04, 2026

Every figure linked to its source

Semaglutide: why weight loss is not the same every week

Before focusing on the scale

This article is informational and does not replace an individual assessment. Semaglutide is a prescription medicine; indication, dose, follow-up, and discontinuation must be decided by a qualified professional.

A question about kilograms per week asks for a clear number. The problem is that a weekly target creates precision that clinical studies do not provide. Weight loss is not usually linear, and an average measured after many months does not describe every seven-day period.

In STEP 1, adults with overweight or obesity, without diabetes, were followed for 68 weeks. The group receiving semaglutide 2.4 mg plus a lifestyle intervention had a mean body-weight reduction of 14.9%, compared with 2.4% in the placebo group, which also received a lifestyle intervention.

STEP 1: group averages after 68 weeks

Mean percentage change in body weight after 68 weeks under the trial conditions.

Semaglutide 2.4 mg + lifestyle intervention−14.9%
Placebo + lifestyle intervention−2.4%

These are study-group averages, not an individual forecast or a constant weekly rate.

Why a weekly average can mislead

Dividing the final result by the number of weeks is only arithmetic. It blends dose escalation, adaptation, periods of greater change, and plateaus. It should not be read as a number that will appear on the scale every week.

Participants also responded differently. A study average helps compare groups under controlled conditions; it does not promise an individual outcome.

What can influence weight change

Starting weight, health conditions, other medicines, sleep, nutrition, activity, dose response, and continuity can all influence the journey. Hydration and sodium can change a weekly reading without representing the same change in body fat.

It is more useful to follow:

  • the weight trend across several weeks;
  • tolerability and adverse effects;
  • sustainable changes in food, movement, sleep, and routine.

How to read the first few weeks

Some regimens start at a lower dose and increase gradually under professional guidance. This period prioritizes adaptation and safety. Comparing the first month with the final average from a long study can lead to premature conclusions.

Follow-up gives context to the trend. The responsible professional can assess whether the current response, symptoms, and strategy make sense for that stage.

Beyond the number on the scale

A meaningful result is not a single number. Measurements, tests when indicated, energy, mobility, sleep, and a person's relationship with food may all inform the assessment. The priority is a safer, sustainable trajectory—not the fastest possible drop.

Want to understand which path may fit your situation?

Start with the health questionnaire. A medical assessment is individual and does not guarantee a prescription.

Start my assessment

What to bring to your appointment

List medicines and supplements, health history, previous treatments, symptoms, routine, and questions. If progress feels too slow, too fast, or comes with significant symptoms, speak with the responsible professional. Never change the dose or schedule on your own.

FAQ

Frequently asked questions

Every figure linked to its source

Sources and references

Read the original materials used to prepare this content.

  1. New England Journal of MedicineOnce-Weekly Semaglutide in Adults with Overweight or Obesity
  2. U.S. Food and Drug AdministrationWegovy — prescribing information
  3. World Health OrganizationWHO guideline on GLP-1 medicines for obesity

Take your questions to partner doctors

Tell us a little about your health to begin an individual assessment. An assessment does not guarantee a prescription.

Start my assessment